This is the first study that has investigated the connection between BMI and prostate cancer-specific outcomes among patients treated with definitive EBRT in the era of dose-escalated IMRT with daily IGRT.
Read MoreHow are the “same” cancers treated differently? Not all gleason scores of 6, 7, or 8+ can be treated equally. How do we individualize the care with the diagnostic tools available to us, when patients present with similar clinicopathologic characteristics?
Read MoreWhat is prostatitis? Quite simply, it is a prostate infection. This condition involves inflammation of the prostate, the small walnut shaped male gland that produces seminal fluid. The direct causes of prostatitis are not fully known by the medical community, but some of the theories include past bacterial infections, irritation from urine back up, lower urinary tract issues, parasites, or viruses.
Read MoreAccording to a new study at the University of Maryland School of Medicine, men who have had testicular cancer may have an increased risk for prostate cancer. While there have been previous studies that have shown an increased risk of prostate cancer in men who have previously had testicular cancer, this is the first one to observe the risk of getting intermediate or high-risk prostate cancer.
Read MoreResearchers from the Pharmacology Department at the Indiana University School of Medicine may have found a future way to cure prostate cancer that metastasizes to the bone.
Read MoreA new study released in the journal, Nature, evaluated a newer approach to treating metastatic prostate cancer through Integrating chemo hormonal therapy and surgery. The method was applied to known or suspected lymph node metastatic prostate cancer.
Read MoreThe Dana-Farber Cancer Institute reported by the Stand Up To Cancer-Prostate Cancer Foundation Dream Team published a new study in the journal, Cell. The findings target a potential new drug therapy for treating prostate cancer. It's the first study of the genomic composition of prostate cancer.
Read MoreThere has been much controversy as to whether or not cycling has an effect on PSA or the emergence of prostate cancer. Although there have been many contradictory studies, overall it seems that riding your bike does not increase your risk for prostate cancer.
Read MoreWhy is this important? Because prostate cancer is to men as breast cancer is to women. And just as with any other cancer, an early understanding of your risk factors and how to potentially reduce them is tremendously valuable. We explore.
Read More
Could obesity be to blame for the higher rates of prostate cancer in African American men? According to a new study from the University Of Washington School Of Nursing and the Fred Hutchinson Cancer Research Center in Seattle – yes, obesity might play a role.
Read MoreThis year at the 110th Annual Scientific Meeting of the American Urological Association (AUA), four new studies will be presented which examine different approaches to what researchers believe are smarter methods to screen for prostate cancer.
Controversy remains surrounding the use of the PSA test to screen for prostate cancer. This is due to the belief that the PSA test may lead to over-diagnosis and over-treatment in men with low-grade, less aggressive forms of the disease. Clinicians have been long awaiting a new approach to screen for prostate cancer because the current PSA test is simply not accurate enough.
Read More
